EPIDEMIOLOGY PROFILE OF PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE (PID) UNDER REGULAR THERAPY WITH OR WITHOUT INTRAVENOUS IMMUNOGLOBULIN (IVIG) REPLACEMENT IN BRAZIL

被引:0
|
作者
Lawrence, T. C. [1 ]
Scancetti, F. [2 ]
Silva, A. M. R. [3 ]
Goudouris, E. [4 ]
Ouricuri, A. L. [4 ]
Costa-Carvalho, B. T. [1 ]
机构
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] Hosp Crianca Dist Fed, Brasilia, DF, Brazil
[3] Univ Fed Pernambuco, Recife, PE, Brazil
[4] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:399 / 399
页数:1
相关论文
共 50 条
  • [21] Hepatitis E infection in adults with primary immunodeficiency with or without immunoglobulin replacement therapy
    Gerard, Laurence
    Garzaro, Margaux
    Ferrer, Venicia
    Malphettes, Marion
    Fieschi, Claire
    Garnier, Jean-Luc
    Just, Nicolas
    Masseau, Agathe
    Delaugerre, Constance
    Izopet, Jacques
    Oksenhendler, Eric
    Abravanel, Florence
    BLOOD TRANSFUSION, 2022, 20 (06) : 516 - 524
  • [22] Flebogamma® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases
    Mark Ballow
    Paul J. Pinciaro
    Timothy Craig
    Gary Kleiner
    James Moy
    Hans D. Ochs
    John Sleasman
    William Smits
    Journal of Clinical Immunology, 2016, 36 : 583 - 589
  • [23] FlebogammaA® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases
    Ballow, Mark
    Pinciaro, Paul J.
    Craig, Timothy
    Kleiner, Gary
    Moy, James
    Ochs, Hans D.
    Sleasman, John
    Smits, William
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (06) : 583 - 589
  • [24] Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment
    Beatriz T. Costa-Carvalho
    Kathleen E. Sullivan
    Patrícia M. Fontes
    Fernanda Aimé-Nobre
    Isabela G. S. Gonzales
    Elaine S. Lima
    Celso Granato
    Maria Isabel de Moraes-Pinto
    Journal of Clinical Immunology, 2018, 38 : 628 - 634
  • [25] Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment
    Costa-Carvalho, Beatriz T.
    Sullivan, Kathleen E.
    Fontes, Patricia M.
    Aime-Nobre, Fernanda
    Gonzales, Isabela G. S.
    Lima, Elaine S.
    Granato, Celso
    de Moraes-Pinto, Maria Isabel
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (05) : 628 - 634
  • [26] AN ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) TREATMENT SETTINGS FOR PRIMARY IMMUNODEFICIENCY PATIENTS: HOME VERSUS OUTPATIENT HOSPITAL
    Quimbo, R.
    Luthra, R.
    Iyer, R.
    Luo, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A91 - A91
  • [27] Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia
    Windegger, Tanja M.
    Nghiem, Son
    Nguyen, Kim-Huong
    Fung, Yoke L.
    Scuffham, Paul A.
    BLOOD TRANSFUSION, 2020, 18 (02) : 96 - 105
  • [28] Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy
    Krishnarajah, Girishanthy
    Lehmann, Jee-Yeon K.
    Ellman, Brian
    Bhak, Rachel H.
    DerSarkissian, Maral
    Leader, Deane, Jr.
    Bullinger, Ann L.
    Duh, Mei Sheng
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (15): : S475 - S481
  • [29] Evaluation of life conditions of patients with primary immunodeficiency (PID) receiving intravenous immunoglobulin (IVIG) followed at unifesp immunology clinic from october 2007 to march 2008
    Lawrence, T. C.
    Surianv, B. R.
    Loureiro, G. L.
    Lessa-Mazzucchelli, J. T.
    Rullo, V
    Costa-Carvalho, B. T.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 199 - 199
  • [30] Tolerability Of Two Different Immunoglobulin Intravenous Product In Patients With Primary Immunodeficiency Disease
    Skoskiewicz, Amanda
    Makhija, Melanie M.
    Fuleihan, Ramsay L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB63 - AB63